Valuation: Psychemedics Corporation

Market Cap 97.91L 86.11L 80L 73.58L 1.38Cr 95Cr 1.4Cr 9.57Cr 3.73Cr 46Cr 3.68Cr 3.6Cr 160.45Cr P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 95.4L 83.91L 77.95L 71.69L 1.34Cr 92Cr 1.37Cr 9.32Cr 3.64Cr 45Cr 3.58Cr 3.5Cr 156.34Cr EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 week-3.61%
Current month-3.61%
1 month+9.09%
3 months+9.09%
6 months+33.33%
Current year+50.00%
1 month 2.4
Extreme 2.4
2.7
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
5.1
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 17/08/2023
Director of Finance/CFO 36 27/11/2023
Corporate Officer/Principal 40 21/09/2023
Director TitleAgeSince
Director/Board Member 64 16/03/2021
Director/Board Member 58 04/04/2022
Director/Board Member 64 12/08/2022
Date Insider Type Main position Quantity % Market Cap.
13/12/24
Powell Anderson Capital Partners
BuyCompany 1,59,700 2.7093%
10/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
10/12/24 Sell

Director

3,20,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-3.61%+8.60%-51.90% 1.52Cr
+0.18%-1.90%+92.05%+436.79% 3.78TCr
+3.40%+3.22%+16.17%+32.76% 2.31TCr
+0.82%-4.16%-25.95%-40.93% 719.07Cr
+2.97%-3.19%+4.17%+74.28% 465.67Cr
-1.52%-2.63%+11.83%+47.54% 294.15Cr
+1.25%+2.74%-23.59%+703.30% 185.85Cr
-2.18%-4.95%-10.86%-62.78% 185.46Cr
+1.64%-4.04%+115.43%-18.35% 182.43Cr
+7.66%+0.97%+14.27%+7.11% 178.71Cr
Average +1.50%-0.63%+20.21%+112.78% 830.49Cr
Weighted average by Cap. +1.42%-0.47%+46.92%+224.50%

Financials

2023 2024
Net sales 2.21Cr 1.94Cr 1.81Cr 1.66Cr 3.11Cr 214Cr 3.17Cr 22Cr 8.42Cr 104.38Cr 8.3Cr 8.12Cr 362.13Cr 1.97Cr 1.73Cr 1.61Cr 1.48Cr 2.77Cr 190.63Cr 2.82Cr 19Cr 7.5Cr 93Cr 7.39Cr 7.23Cr 322.58Cr
Net income -41.54L -36.53L -33.94L -31.22L -58.54L -40Cr -59.59L -4.06Cr -1.58Cr -20Cr -1.56Cr -1.53Cr -68Cr -18.61L -16.37L -15.21L -13.98L -26.23L -18Cr -26.7L -1.82Cr -70.92L -8.79Cr -69.87L -68.35L -30Cr
Net Debt 3L 3L 3L 3L 5L 3.23Cr 5L 32.63L 12.73L 1.58Cr 12.54L 12.27L 5.47Cr -3L -2L -2L -2L -4L -2.43Cr -4L -24.52L -10L -1.19Cr -9L -9L -4.11Cr
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
  1. Stock Market
  2. Stocks
  3. PMDI Stock